Genome-wide Mapping of RELA(p65) Binding Identifies E2F1 as a Transcriptional Activator Recruited by NF-κB upon TLR4 Activation

Molecular Cell

Volumn 27, Issue 4, 2007, Pages 622-635

  Lim, Ching Aeng ^a,b   Yao, Fei ^a   Wong, Joyce Jing Yi ^a,b   George, Joshy ^a   Xu, Han ^a   Chiu, Kuo Ping ^a   Sung, Wing Kin ^a,c   Lipovich, Leonard ^a   Vega, Vinsensius B ^a   Chen, Joanne ^d   Shahab, Atif ^d   Zhao, Xiao Dong ^a   Hibberd, Martin ^a   Wei, Chia Lin ^a   Lim, Bing ^a,e   Ng, Huck Hui ^a,c   Ruan, Yijun ^a   Chin, Keh Chuang ^a,b  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d BIOINFORMATICS INSTITUTE   (Singapore)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

DNA; SIGNALING

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTEIN P50; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MAPPING; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN CELL; MONOCYTE; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

EID: 34547838179     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2007.06.038     Document Type: Article

References (46)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
2. Attwooll C., Lazzerini Denchi E., and Helin K. The E2F family: specific functions and overlapping interests. EMBO J. 23 (2004) 4709-4716
3. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
4. Bieda M., Xu X., Singer M.A., Green R., and Farnham P.J. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 16 (2006) 595-605
5. Campbell K.J., Rocha S., and Perkins N.D. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol. Cell 13 (2004) 853-865
6. Cawley S., Bekiranov S., Ng H.H., Kapranov P., Sekinger E.A., Kampa D., Piccolboni A., Sementchenko V., Cheng J., Williams A.J., et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116 (2004) 499-509
7. Chen C.G., Malliaros J., Katerelos M., d'Apice A.J., and Pearse M.J. Inhibition of NF-kappaB activation by a dominant-negative mutant of IkappaBalpha. Mol. Immunol. 33 (1996) 57-61
8. Cook D.N. The role of MIP-1 alpha in inflammation and hematopoiesis. J. Leukoc. Biol. 59 (1996) 61-66
9. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20 (2002) S1-S13
10. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
11. Guo Z., Boekhoudt G.H., and Boss J.M. Role of the intronic enhancer in tumor necrosis factor-mediated induction of manganous superoxide dismutase. J. Biol. Chem. 278 (2003) 23570-23578
12. Helt A.M., and Galloway D.A. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24 (2003) 159-169
13. Herrera R.E., Makela T.P., and Weinberg R.A. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell 7 (1996) 1335-1342
14. Igaz P., Toth S., and Falus A. Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflamm. Res. 50 (2001) 435-441
15. Johnson D.G., Schwarz J.K., Cress W.D., and Nevins J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365 (1993) 349-352
16. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
17. Krappmann D., Wegener E., Sunami Y., Esen M., Thiel A., Mordmuller B., and Scheidereit C. The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol. Cell. Biol. 24 (2004) 6488-6500
18. Kullberg M.C., Jankovic D., Feng C.G., Hue S., Gorelick P.L., McKenzie B.S., Cua D.J., Powrie F., Cheever A.W., Maloy K.J., and Sher A. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203 (2006) 2485-2494
19. Kundu M., Guermah M., Roeder R.G., Amini S., and Khalili K. Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription. J. Biol. Chem. 272 (1997) 29468-29474
20. Kunsch C., and Rosen C.A. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13 (1993) 6137-6146
21. Langowski J.L., Zhang X., Wu L., Mattson J.D., Chen T., Smith K., Basham B., McClanahan T., Kastelein R.A., and Oft M. IL-23 promotes tumour incidence and growth. Nature 442 (2006) 461-465
22. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., Tsai M.J., and O'Malley B.W. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97 (1999) 17-27
23. Lawrence T., Willoughby D.A., and Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2 (2002) 787-795
24. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saib A., and Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 308 (2005) 557-560
25. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., and Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270 (1995) 14255-14258
26. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38 (2006) 431-440
27. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., Rinn J.L., Nelson F.K., Miller P., Gerstein M., et al. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA 100 (2003) 12247-12252
28. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31 (2003) 374-378
29. Mori N., Yamada Y., Ikeda S., Yamasaki Y., Tsukasaki K., Tanaka Y., Tomonaga M., Yamamoto N., and Fujii M. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100 (2002) 1828-1834
30. Natoli G., Saccani S., Bosisio D., and Marazzi I. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 6 (2005) 439-445
31. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., and Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122 (2005) 707-721
32. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
33. Pavesi G., Mauri G., and Pesole G. An algorithm for finding signals of unknown length in DNA sequences. Bioinformatics 17 Suppl 1 (2001) S207-S214
34. Plevy S.E., Gemberling J.H., Hsu S., Dorner A.J., and Smale S.T. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17 (1997) 4572-4588
35. Sanjabi S., Hoffmann A., Liou H.C., Baltimore D., and Smale S.T. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97 (2000) 12705-12710
36. Schreiber J., Jenner R.G., Murray H.L., Gerber G.K., Gifford D.K., and Young R.A. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 103 (2006) 5899-5904
37. Su J.L., Yang P.C., Shih J.Y., Yang C.Y., Wei L.H., Hsieh C.Y., Chou C.H., Jeng Y.M., Wang M.Y., Chang K.J., et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9 (2006) 209-223
38. Taganov K.D., Boldin M.P., Chang K.J., and Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12481-12486
39. Tanaka H., Matsumura I., Ezoe S., Satoh Y., Sakamaki T., Albanese C., Machii T., Pestell R.G., and Kanakura Y. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol. Cell 9 (2002) 1017-1029
40. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 (2006) 207-219
41. Weighardt H., Jusek G., Mages J., Lang R., Hoebe K., Beutler B., and Holzmann B. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur. J. Immunol. 34 (2004) 558-564
42. Wietek C., Miggin S.M., Jefferies C.A., and O'Neill L.A. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278 (2003) 50923-50931
43. Wikonkal N.M., Remenyik E., Knezevic D., Zhang W., Liu M., Zhao H., Berton T.R., Johnson D.G., and Brash D.E. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat. Cell Biol. 5 (2003) 655-660
44. Willingham A.T., Orth A.P., Batalov S., Peters E.C., Wen B.G., Aza-Blanc P., Hogenesch J.B., and Schultz P.G. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309 (2005) 1570-1573
45. Yang A., Zhu Z., Kapranov P., McKeon F., Church G.M., Gingeras T.R., and Struhl K. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol. Cell 24 (2006) 593-602
46. Ying L., Marino J., Hussain S.P., Khan M.A., You S., Hofseth A.B., Trivers G.E., Dixon D.A., Harris C.C., and Hofseth L.J. Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res. 65 (2005) 9132-9136